<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss-of-function mutations in Patched (Ptch1) are implicated in constitutive activation of the Sonic hedgehog pathway in human <z:hpo ids='HP_0002671'>basal cell carcinomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e>), and inherited Ptch1 mutations underlie <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome in which a typical feature is multiple <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> occurring with greater incidence in portals of radiotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Mice in which one copy of Ptch1 is inactivated show increased susceptibility to <z:mp ids='MP_0002020'>spontaneous tumor</z:mp> development and hypersensitivity to radiation-induced <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, providing an ideal in vivo model to study the typical pathologies associated with <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore examined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> development in control and irradiated Ptch1(neo67/+) mice </plain></SENT>
<SENT sid="3" pm="."><plain>We show that unirradiated mice develop putative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> precursor lesions, i.e., basaloid hyperproliferation areas arising from both follicular and interfollicular epithelium, and that these lesions progress to nodular and infiltrative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e> only in irradiated mice </plain></SENT>
<SENT sid="4" pm="."><plain>Data of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> incidence, multiplicity, and latency support the notion of epidermal hyperproliferations, nodular and infiltrative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e>-like <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> representing different stages of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development </plain></SENT>
<SENT sid="5" pm="."><plain>This is additionally supported by the pattern of p53 protein expression observed in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> subtypes and by the finding of retention of the <z:mpath ids='MPATH_458'>normal</z:mpath> remaining Ptch1 allele in <z:hpo ids='HP_0000001'>all</z:hpo> nodular, circumscribed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e> analyzed compared with its constant loss in infiltrative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Our data suggest chronological <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> from basaloid hyperproliferations to nodular and then infiltrative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> occurring in a stepwise fashion through the accumulation of sequential genetic alterations </plain></SENT>
</text></document>